Clinical Trial Update: Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy [Phase 3]

View source ↗

Summary

A Phase 3 study is evaluating apalutamide with radiotherapy and an LHRH agonist in prostate cancer patients after prostatectomy, and is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Erleada (apalutamide) (apalutamide)
• Lupron (leuprolide) (leuprolide)

Snippet

Sponsor: UNICANCER | Conditions: Prostate Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING